Stock Rating Upgrade
The Value Trend Rating for Corcept Therapeutics Inc (NASDAQ: CORT) improved recently from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Corcept Therapeutics Inc (NASDAQ: CORT) stock closed at $56.01 on 3/14/25 after a large increase of 2.1%. However, below average trading volume at 72% of normal accompanied the advance. The stock has risen 3.1% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Corcept Therapeutics has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Corcept Therapeutics has a neutral Appreciation Score of 54 but a very high Power Rating of 86, resulting in the Positive Value Trend Rating.
Be the first to comment